Abstract
Summary
This report describes the immunobiological characterization of an antiserum to commercial human chorionic gonadotropin. This antiserum identified human chorionic gonadotropin of benign or malignant trophoblastic origin in serum or urine and neutralized its biological activity.
Get full access to this article
View all access options for this article.